The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract - PubMed (original) (raw)
. 1998 Jun 11;393(6685):591-4.
doi: 10.1038/31261.
S Hirota, H Iizasa, H Yoshida, K Kawabata, Y Kataoka, Y Kitamura, K Matsushima, N Yoshida, S Nishikawa, T Kishimoto, T Nagasawa
Affiliations
- PMID: 9634237
- DOI: 10.1038/31261
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
K Tachibana et al. Nature. 1998.
Abstract
Vascularization of organs generally occurs by remodelling of the preexisting vascular system during their differentiation and growth to enable them to perform their specific functions during development. The molecules required by early vascular systems, many of which are receptor tyrosine kinases and their ligands, have been defined by analysis of mutant mice. As most of these mice die during early gestation before many of their organs have developed, the molecules responsible for vascularization during organogenesis have not been identified. The cell-surface receptor CXCR4 is a seven-transmembrane-spanning, G-protein-coupled receptor for the CXC chemokine PBSF/SDF-1 (for pre-B-cell growth-stimulating factor/stromal-cell-derived factor), which is responsible for B-cell lymphopoiesis, bone-marrow myelopoiesis and cardiac ventricular septum formation. CXCR4 also functions as a co-receptor for T-cell-line tropic human immunodeficiency virus HIV-1. Here we report that CXCR4 is expressed in developing vascular endothelial cells, and that mice lacking CXCR4 or PBSF/SDF-1 have defective formation of the large vessels supplying the gastrointestinal tract. In addition, mice lacking CXCR4 die in utero and are defective in vascular development, haematopoiesis and cardiogenesis, like mice lacking PBSF/SDF-1, indicating that CXCR4 is a primary physiological receptor for PBSF/SDF-1. We conclude that PBSF/SDF-1 and CXCR4 define a new signalling system for organ vascularization.
Comment in
- Chemokines beyond inflammation.
Horuk R. Horuk R. Nature. 1998 Jun 11;393(6685):524-5. doi: 10.1038/31116. Nature. 1998. PMID: 9634228 No abstract available.
Similar articles
- A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection.
Nagasawa T, Tachibana K, Kishimoto T. Nagasawa T, et al. Semin Immunol. 1998 Jun;10(3):179-85. doi: 10.1006/smim.1998.0128. Semin Immunol. 1998. PMID: 9653044 Review. - Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1.
Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T. Nagasawa T, et al. Nature. 1996 Aug 15;382(6592):635-8. doi: 10.1038/382635a0. Nature. 1996. PMID: 8757135 - A chemokine, SDF-1/PBSF, and its receptor, CXC chemokine receptor 4, as mediators of hematopoiesis.
Nagasawa T. Nagasawa T. Int J Hematol. 2000 Dec;72(4):408-11. Int J Hematol. 2000. PMID: 11197205 Review. - Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development.
Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Zou YR, et al. Nature. 1998 Jun 11;393(6685):595-9. doi: 10.1038/31269. Nature. 1998. PMID: 9634238 - Role of chemokine SDF-1/PBSF and its receptor CXCR4 in blood vessel development.
Nagasawa T. Nagasawa T. Ann N Y Acad Sci. 2001 Dec;947:112-5; discussion 115-6. doi: 10.1111/j.1749-6632.2001.tb03933.x. Ann N Y Acad Sci. 2001. PMID: 11795258
Cited by
- Pan-cancer integrative analyses dissect the remodeling of endothelial cells in human cancers.
Li J, Wang D, Tang F, Ling X, Zhang W, Zhang Z. Li J, et al. Natl Sci Rev. 2024 Jul 11;11(9):nwae231. doi: 10.1093/nsr/nwae231. eCollection 2024 Sep. Natl Sci Rev. 2024. PMID: 39345334 Free PMC article. - Allosteric modulation of the CXCR4:CXCL12 axis by targeting receptor nanoclustering via the TMV-TMVI domain.
García-Cuesta EM, Martínez P, Selvaraju K, Ulltjärn G, Gómez Pozo AM, D'Agostino G, Gardeta S, Quijada-Freire A, Blanco Gabella P, Roca C, Hoyo DD, Jiménez-Saiz R, García-Rubia A, Soler Palacios B, Lucas P, Ayala-Bueno R, Santander Acerete N, Carrasco Y, Oscar Sorzano C, Martinez A, Campillo NE, Jensen LD, Rodriguez Frade JM, Santiago C, Mellado M. García-Cuesta EM, et al. Elife. 2024 Sep 9;13:RP93968. doi: 10.7554/eLife.93968. Elife. 2024. PMID: 39248648 Free PMC article. - The story of clobenpropit and CXCR4: can be an effective drug in cancer and autoimmune diseases?
Abbasifard M, Bagherzadeh K, Khorramdelazad H. Abbasifard M, et al. Front Pharmacol. 2024 Jul 12;15:1410104. doi: 10.3389/fphar.2024.1410104. eCollection 2024. Front Pharmacol. 2024. PMID: 39070795 Free PMC article. Review. - The complex nature of CXCR4 mutations in WHIM syndrome.
Rodríguez-Frade JM, González-Granado LI, Santiago CA, Mellado M. Rodríguez-Frade JM, et al. Front Immunol. 2024 Jul 5;15:1406532. doi: 10.3389/fimmu.2024.1406532. eCollection 2024. Front Immunol. 2024. PMID: 39035006 Free PMC article. Review. - Disruption of placental ACKR3 impairs growth and hematopoietic development of offspring.
Fukuoka A, Wilson GJ, Pitmon E, Koumbas Foley L, Johnsson H, Pingen M, Graham GJ. Fukuoka A, et al. Development. 2024 Feb 15;151(4):dev202333. doi: 10.1242/dev.202333. Epub 2024 Feb 23. Development. 2024. PMID: 38300826 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials